Based on the available literature and several factors potentially reducing the concentrations of natriuretic peptides in people with obesity, we think that NT-proBNP is not a good indicator of the CV function in such individuals, at least when it is in lower concentrations [36–40]. The gene discussed is NPPB; the disease is obesity due to melanocortin 4 receptor deficiency.